Fingerprint
Dive into the research topics of 'Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma
Hiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, Junji Furuse, Hiroyuki Furukawa, Tatsuhiro Shibata
Research output: Contribution to journal › Article › peer-review
24
Citations
(Scopus)